Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes

Tamer A. Ahmed, Mark D. Buzzelli, Charles H. Lang, John B. Capen, Margaret L. Shumate, Maithili Navaratnarajah, Murali Nagarajan, Robert N. Cooney

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

During systemic inflammation, the liver becomes unresponsive to growth hormone (GH), resulting in decreased plasma insulin-like growth factor-I (IGF-I) with concomitant reductions in lean body mass. Transgenic mice that overexpress IL-6 also demonstrate impaired growth and decreased IGF-I. To determine whether IL-6 directly inhibits GH-inducible gene expression, CWSV-1 hepatocytes were incubated with IL-6 (10 ng/ml), then stimulated with recombinant human GH (500 ng/ml, 18 h). The increase in IGF-I and serine protease inhibitor 2.1 (Spi 2.1) mRNA in GH-treated cells was inhibited by treatment with IL-6 for 24 h. To investigate potential mechanisms, we examined the effects of IL-6 on GH receptor (GHR) expression and GH signaling via the JAK/signal transducer and activator of transcription (STAT) and MAP kinase pathways. Incubation of cells with IL-6 (10 ng/ml, 24 h) had no effect on GHR abundance or signaling proteins JAK2, STAT5b, and ERK1/2. Although GH transiently increased (2- to 5-fold) the tyrosine phosphorylation of GHR, JAK2, STAT5b, and ERK1/2, IL-6 did not alter these phosphorylation events. However, nuclear protein from IL-6-treated cells demonstrated reduced STAT5 DNA binding (by EMSA) at 15 min (-20%) and 60 min (-43%) after GH stimulation. To determine whether IL-6 inhibits GH-inducible promoter activity, CWSV-1 cells were transfected with Spi 2.1 or prolactin receptor promoter luciferase vectors, incubated with or without IL-6, then stimulated with GH. The induction of both Spi 2.1 (7.5-fold) and prolactin receptor (4-fold) promoter activity by GH was inhibited by IL-6. In summary, IL-6 mediates hepatic GH resistance by a time-dependent inhibition of GH-inducible promoter activity that is associated with reductions in STAT5 DNA binding.

Original languageEnglish (US)
Pages (from-to)G1793-G1803
JournalAmerican Journal of Physiology - Gastrointestinal and Liver Physiology
Volume292
Issue number6
DOIs
StatePublished - Jun 1 2007

Fingerprint

Growth Hormone
Hepatocytes
Interleukin-6
Gene Expression
Serine Proteinase Inhibitors
Insulin-Like Growth Factor I
Prolactin Receptors
Interleukin-10
Phosphorylation
STAT5 Transcription Factor
Somatotropin Receptors
Human Growth Hormone
Liver
DNA
Nuclear Proteins
Luciferases
Transducers
Transgenic Mice
Tyrosine
Phosphotransferases

All Science Journal Classification (ASJC) codes

  • Physiology
  • Hepatology
  • Gastroenterology
  • Physiology (medical)

Cite this

Ahmed, Tamer A. ; Buzzelli, Mark D. ; Lang, Charles H. ; Capen, John B. ; Shumate, Margaret L. ; Navaratnarajah, Maithili ; Nagarajan, Murali ; Cooney, Robert N. / Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes. In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 2007 ; Vol. 292, No. 6. pp. G1793-G1803.
@article{157126795a884e158391ddc067aed883,
title = "Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes",
abstract = "During systemic inflammation, the liver becomes unresponsive to growth hormone (GH), resulting in decreased plasma insulin-like growth factor-I (IGF-I) with concomitant reductions in lean body mass. Transgenic mice that overexpress IL-6 also demonstrate impaired growth and decreased IGF-I. To determine whether IL-6 directly inhibits GH-inducible gene expression, CWSV-1 hepatocytes were incubated with IL-6 (10 ng/ml), then stimulated with recombinant human GH (500 ng/ml, 18 h). The increase in IGF-I and serine protease inhibitor 2.1 (Spi 2.1) mRNA in GH-treated cells was inhibited by treatment with IL-6 for 24 h. To investigate potential mechanisms, we examined the effects of IL-6 on GH receptor (GHR) expression and GH signaling via the JAK/signal transducer and activator of transcription (STAT) and MAP kinase pathways. Incubation of cells with IL-6 (10 ng/ml, 24 h) had no effect on GHR abundance or signaling proteins JAK2, STAT5b, and ERK1/2. Although GH transiently increased (2- to 5-fold) the tyrosine phosphorylation of GHR, JAK2, STAT5b, and ERK1/2, IL-6 did not alter these phosphorylation events. However, nuclear protein from IL-6-treated cells demonstrated reduced STAT5 DNA binding (by EMSA) at 15 min (-20{\%}) and 60 min (-43{\%}) after GH stimulation. To determine whether IL-6 inhibits GH-inducible promoter activity, CWSV-1 cells were transfected with Spi 2.1 or prolactin receptor promoter luciferase vectors, incubated with or without IL-6, then stimulated with GH. The induction of both Spi 2.1 (7.5-fold) and prolactin receptor (4-fold) promoter activity by GH was inhibited by IL-6. In summary, IL-6 mediates hepatic GH resistance by a time-dependent inhibition of GH-inducible promoter activity that is associated with reductions in STAT5 DNA binding.",
author = "Ahmed, {Tamer A.} and Buzzelli, {Mark D.} and Lang, {Charles H.} and Capen, {John B.} and Shumate, {Margaret L.} and Maithili Navaratnarajah and Murali Nagarajan and Cooney, {Robert N.}",
year = "2007",
month = "6",
day = "1",
doi = "10.1152/ajpgi.00547.2006",
language = "English (US)",
volume = "292",
pages = "G1793--G1803",
journal = "American Journal of Physiology",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "6",

}

Ahmed, TA, Buzzelli, MD, Lang, CH, Capen, JB, Shumate, ML, Navaratnarajah, M, Nagarajan, M & Cooney, RN 2007, 'Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes', American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 292, no. 6, pp. G1793-G1803. https://doi.org/10.1152/ajpgi.00547.2006

Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes. / Ahmed, Tamer A.; Buzzelli, Mark D.; Lang, Charles H.; Capen, John B.; Shumate, Margaret L.; Navaratnarajah, Maithili; Nagarajan, Murali; Cooney, Robert N.

In: American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 292, No. 6, 01.06.2007, p. G1793-G1803.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interleukin-6 inhibits growth hormone-mediated gene expression in hepatocytes

AU - Ahmed, Tamer A.

AU - Buzzelli, Mark D.

AU - Lang, Charles H.

AU - Capen, John B.

AU - Shumate, Margaret L.

AU - Navaratnarajah, Maithili

AU - Nagarajan, Murali

AU - Cooney, Robert N.

PY - 2007/6/1

Y1 - 2007/6/1

N2 - During systemic inflammation, the liver becomes unresponsive to growth hormone (GH), resulting in decreased plasma insulin-like growth factor-I (IGF-I) with concomitant reductions in lean body mass. Transgenic mice that overexpress IL-6 also demonstrate impaired growth and decreased IGF-I. To determine whether IL-6 directly inhibits GH-inducible gene expression, CWSV-1 hepatocytes were incubated with IL-6 (10 ng/ml), then stimulated with recombinant human GH (500 ng/ml, 18 h). The increase in IGF-I and serine protease inhibitor 2.1 (Spi 2.1) mRNA in GH-treated cells was inhibited by treatment with IL-6 for 24 h. To investigate potential mechanisms, we examined the effects of IL-6 on GH receptor (GHR) expression and GH signaling via the JAK/signal transducer and activator of transcription (STAT) and MAP kinase pathways. Incubation of cells with IL-6 (10 ng/ml, 24 h) had no effect on GHR abundance or signaling proteins JAK2, STAT5b, and ERK1/2. Although GH transiently increased (2- to 5-fold) the tyrosine phosphorylation of GHR, JAK2, STAT5b, and ERK1/2, IL-6 did not alter these phosphorylation events. However, nuclear protein from IL-6-treated cells demonstrated reduced STAT5 DNA binding (by EMSA) at 15 min (-20%) and 60 min (-43%) after GH stimulation. To determine whether IL-6 inhibits GH-inducible promoter activity, CWSV-1 cells were transfected with Spi 2.1 or prolactin receptor promoter luciferase vectors, incubated with or without IL-6, then stimulated with GH. The induction of both Spi 2.1 (7.5-fold) and prolactin receptor (4-fold) promoter activity by GH was inhibited by IL-6. In summary, IL-6 mediates hepatic GH resistance by a time-dependent inhibition of GH-inducible promoter activity that is associated with reductions in STAT5 DNA binding.

AB - During systemic inflammation, the liver becomes unresponsive to growth hormone (GH), resulting in decreased plasma insulin-like growth factor-I (IGF-I) with concomitant reductions in lean body mass. Transgenic mice that overexpress IL-6 also demonstrate impaired growth and decreased IGF-I. To determine whether IL-6 directly inhibits GH-inducible gene expression, CWSV-1 hepatocytes were incubated with IL-6 (10 ng/ml), then stimulated with recombinant human GH (500 ng/ml, 18 h). The increase in IGF-I and serine protease inhibitor 2.1 (Spi 2.1) mRNA in GH-treated cells was inhibited by treatment with IL-6 for 24 h. To investigate potential mechanisms, we examined the effects of IL-6 on GH receptor (GHR) expression and GH signaling via the JAK/signal transducer and activator of transcription (STAT) and MAP kinase pathways. Incubation of cells with IL-6 (10 ng/ml, 24 h) had no effect on GHR abundance or signaling proteins JAK2, STAT5b, and ERK1/2. Although GH transiently increased (2- to 5-fold) the tyrosine phosphorylation of GHR, JAK2, STAT5b, and ERK1/2, IL-6 did not alter these phosphorylation events. However, nuclear protein from IL-6-treated cells demonstrated reduced STAT5 DNA binding (by EMSA) at 15 min (-20%) and 60 min (-43%) after GH stimulation. To determine whether IL-6 inhibits GH-inducible promoter activity, CWSV-1 cells were transfected with Spi 2.1 or prolactin receptor promoter luciferase vectors, incubated with or without IL-6, then stimulated with GH. The induction of both Spi 2.1 (7.5-fold) and prolactin receptor (4-fold) promoter activity by GH was inhibited by IL-6. In summary, IL-6 mediates hepatic GH resistance by a time-dependent inhibition of GH-inducible promoter activity that is associated with reductions in STAT5 DNA binding.

UR - http://www.scopus.com/inward/record.url?scp=34447508349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447508349&partnerID=8YFLogxK

U2 - 10.1152/ajpgi.00547.2006

DO - 10.1152/ajpgi.00547.2006

M3 - Article

C2 - 17395896

AN - SCOPUS:34447508349

VL - 292

SP - G1793-G1803

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1849

IS - 6

ER -